Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Long Noncoding RNA RP11-89K21.1 Interacts with miR-146a/b-5p to Promote Proliferation and Gefitinib Resistance Through Regulating RHPN2 and RhoA/ROCK Pathway in Lung Adenocarcinoma.

  • Authors : Chen H; Department of Tuberculosis, Wuxi No. 5 People's Hospital, Wuxi, China.; Shen D

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Jun; Vol. 38 (5), pp. 282-292. Date of Electronic Publication: 2021 Apr 20.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Long Noncoding RNA IPW Is a Novel Diagnostic and Predictive Biomarker in Lung Adenocarcinoma.

  • Authors : Liu Z; Department of Oncology, Taixing People's Hospital, Taixing, China.; Jiang H

Subjects: RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/genetics ; RNA, Long Noncoding*/RNA, Long Noncoding*/RNA, Long Noncoding*/metabolism ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/diagnosis

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2023 Jan; Vol. 27 (1), pp. 18-26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
Academic Journal

miR-19a-3p Facilitates Lung Adenocarcinoma Cell Phenotypes by Inhibiting TEK .

  • Authors : Peng T; Department of Thoracic and Cardiovascular Surgery, Huangshi Central Hospital (Affiliated Hospital of Hubei Polytechnic University), Edong Healthcare Group, Huangshi, China.; Yang F

Subjects: Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/pathology ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/genetics ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/pathology

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2022 Sep; Vol. 37 (7), pp. 589-601. Date of Electronic Publication: 2021 Jan 25.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Pretreatment to Posttreatment Hypoxia Inducible Factor-1α Ratios as a Potentially Predictive Marker for First-Line Treatment in Nonsmall Cell Lung Cancer Patients without Known Driver Mutations.

  • Authors : Hu M; Oncology Department, Beijing Chest Hospital of Capital Medical University, Beijing, China.; Zhang T

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*blood ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*blood ; Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/Hypoxia-Inducible Factor 1, alpha Subunit/*blood

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2020 Dec; Vol. 24 (12), pp. 798-803.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
Academic Journal

The Role of Interleukin-31 Polymorphisms in Non-Small Cell Lung Cancer Genetic Susceptibility and Clinical Outcome.

  • Authors : Yang Y; 1 Laboratory of Pathology, West China Hospital, Sichuan University, Key Laboratory of Transplant Engineering and Immunology, Sichuan University , Chengdu, China .; Li L

Subjects: Genetic Predisposition to Disease* ; Polymorphism, Genetic*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*genetics

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2018 May; Vol. 22 (5), pp. 314-319.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print Cited

Record details

×
Academic Journal

LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.

  • Authors : Li L; 1 Hongqiao International Institute of Medicine, Shanghai Tongren Hospital and Faculty of Public Health, Shanghai Jiao Tong University School of Medicine , Shanghai, China .; Feng T

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*genetics ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*genetics ; RNA, Long Noncoding/RNA, Long Noncoding/RNA, Long Noncoding/*genetics

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2018 Jan; Vol. 22 (1), pp. 20-28. Date of Electronic Publication: 2018 Jan 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print-Electronic

Record details

×
Academic Journal

(99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.

  • Authors : Zhang Z; 1 Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University , Shijiazhuang, China .; Zhao X

Subjects: Organotechnetium Compounds* ; Peptides, Cyclic* ; Radiopharmaceuticals*

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2016 Sep; Vol. 31 (7), pp. 238-45. Date of Electronic Publication: 2016 Aug 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer.

  • Authors : Wang HT; 1 Department of Radiation Oncology, The Fourth Affiliated Hospital of China Medical University , Shenyang, People's Republic of China .; Gao Y

Subjects: Genetic Predisposition to Disease* ; Polymorphism, Genetic*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*genetics

  • Source: Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2014 Nov; Vol. 18 (11), pp. 736-40. Date of Electronic Publication: 2014 Sep 16.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101494210 Publication Model: Print-Electronic

Record details

×
Academic Journal

Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.

  • Authors : Zheng X; 1 School of Laboratory Medicine, Dalian Medical University , Dalian, Liaoning, China .; Wang Y

Subjects: Gene Expression Regulation, Neoplastic*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*genetics ; Cyclin D1/Cyclin D1/Cyclin D1/*genetics

  • Source: Nucleic acid therapeutics [Nucleic Acid Ther] 2014 Jun; Vol. 24 (3), pp. 210-6. Date of Electronic Publication: 2014 Feb 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic

Record details

×
Academic Journal

CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of Toll-like receptor 9.

  • Authors : Yan L; Department of Oncology, Jinshan Hospital, Fudan University, Shanghai, China.; Xu G

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*radiotherapy ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*drug therapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2013 Sep; Vol. 28 (7), pp. 559-64. Date of Electronic Publication: 2013 May 24.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  30 results for ""Lung Neoplasms""